InflaRx intends to engage with EMA regarding both vilobelimab and izicopan to evaluate the regulatory path to approval in ANCA-associated vasculitis (AAV) The Company is assessing the most efficient ...
In recent years, the frequency of weather-related natural disasters—cyclones, torrential rains, floods—has increased as a consequence of global warming. These disasters cause billions of dollars in ...
Solving complex optimization problems is central to many modern technologies, from logistics and financial modeling to chip ...
National security, unlocked. Each Thursday, host Mary Louise Kelly and a team of NPR correspondents discuss the biggest national security news of the week. With decades of reporting from battlefields ...